Last updated: July 29, 2025
Introduction
The patent KR20050090410, filed in South Korea, pertains to innovations in the pharmaceutical or biotechnological fields. An understanding of its scope, claims, and the surrounding patent landscape is critical for stakeholders such as pharmaceutical companies, patent strategists, and R&D entities. This analysis delves into the patent's legal scope, claims, and how it integrates within the broader intellectual property environment.
Patent Scope and Abstract Overview
The patent KR20050090410 was filed with the Korean Intellectual Property Office (KIPO) with the intent of protecting novel advancements—likely in drug composition, delivery systems, or active ingredient modifications. While specifics depend on the detailed patent document, typical scope involves aspects such as:
- Novel chemical entities or derivatives.
- Unique formulations or delivery mechanisms.
- Methods of manufacturing or use.
The abstract describes the patent’s core innovation, which often centers on an active pharmaceutical ingredient (API), improved bioavailability, or targeted therapeutic effects. The scope is designed to protect the invention against both direct and equivalent implementations within the Korean market.
Claims Analysis
The claims in KR20050090410 form the backbone of the patent's legal protection. They delineate the boundaries of the invention, determining what constitutes infringement and what is outside the patent’s scope.
Types of Claims
Typically, patent claims are divided into:
- Independent Claims: Define the broadest scope, covering the core inventive concept.
- Dependent Claims: Provide specific embodiments, refining the independent claims with additional features or limitations.
Main Claim Elements
Based on standard practice and available patent documents, key elements of the claims likely include:
- Chemical Composition: The patent may claim a specific compound or a class of compounds, possibly a novel API with high efficacy or reduced side effects.
- Preparation Method: Claims might detail a novel synthesis process improving yield or purity.
- Therapeutic Use: The patent may specify particular indications, such as treatment for a specific disease (e.g., cancer, infectious diseases).
- Formulation and Delivery: Claims might encompass unique dosage forms, sustained-release systems, or targeted delivery mechanisms.
Claim Scope Evaluation
The scope of the patent appears to aim at broad protection, covering both the chemical entity and its potential uses, which allows for strategic enforcement against competitors. However, the scope's definitiveness depends on the exact language used—whether it employs open or closed terminology, such as "comprising" or "consisting of"—which significantly impacts enforceability.
In addition, the patent likely emphasizes inventive step over prior art, asserting novelty based on a unique structural feature, method, or utility. The scope may also encompass derivatives or analogs, as long as they fall within the inventive concept.
Patent Landscape Context in South Korea
Legal and Market Environment
South Korea boasts a robust patent regime suited for pharmaceutical innovations. The Patent Act emphasizes patentability criteria such as novelty, inventive step, and industrial applicability. It aligns with international standards (e.g., TRIPS), fostering a competitive environment.
Prevalent Patent Filing Trends
The Korean patent landscape displays increasing filings for pharmaceuticals, especially in biologics, targeted therapies, and novel chemical entities. Patent applications typically seek broad claims, followed by divisionals and subsequent strategic filings in jurisdictions like the US and Europe.
Key Patent Families and Overlapping Patents
The patent KR20050090410 exists within a dense network of patent families, including:
- International applications (PCT filings).
- Patent families representing related compounds or formulations.
- Competitors' filings aiming to secure similar therapeutic areas.
In many instances, patent examiners scrutinize for potential overlaps, leading to narrowing of claims or licensing agreements. It is common for patents in this space to face patent oppositions or challenges, especially in later stages.
Major Patent Assignees
Patent landscape analyses typically show leading pharmaceutical companies and biotech firms as active filers in South Korea, including domestic giants such as Hanmi Pharmaceutical, Celltrion, and global players like Novo Nordisk and Pfizer.
Patent Term and Lifecycle Management
The typical patent term in Korea is 20 years from filing date. Given the age of patent KR20050090410 (filing approximately 2005), it either is nearing expiry or may have been extended via supplementary protection certificates (SPC), depending on the jurisdiction and regulatory approvals.
Strategic Implications
The patent’s broad claims, coupled with the dynamic Korean patent landscape, imply strategic importance. It may serve as a core patent in defending market share or licensing negotiations. Moreover, understanding its scope helps in shaping patent portfolios to avoid infringement or to identify freedom-to-operate (FTO) opportunities.
Conclusion
KR20050090410 embodies an inventive effort to protect novel drug-related innovations within South Korea. Its claims likely encompass a broad chemical or formulation space, intended to secure competitive advantage in the pharmaceutical market. Given Korea’s reputation for aggressive patent filing and strategic patenting, this patent’s landscape is intertwined with numerous related patents, emphasizing the importance of precise claim drafting and landscape analysis.
Key Takeaways
- The patent’s scope strategically balances broad coverage with specific claims, protecting core innovations while leaving room for derivative inclusions.
- In the competitive Korean pharmaceutical environment, this patent’s strength depends on the language of claims and ongoing patent prosecution.
- Understanding the interconnected patent landscape enables effective freedom-to-operate assessments and licensing strategies.
- As the patent approaches expiration, companies should consider supplemental protections, such as formulation patents or method of use claims.
- Continuous monitoring for patent expirations, oppositions, or infringements remains vital to maintain market position.
FAQs
1. What is the primary innovative feature protected by KR20050090410?
The core innovation typically involves a novel chemical compound, formulation, or method of manufacturing. Precise details depend on the full patent description, but generally, it addresses enhanced efficacy, stability, or targeted delivery.
2. How does this patent fit within the broader South Korean patent landscape?
It aligns with Korea’s strategic emphasis on protecting chemical and pharmaceutical innovations, often overlapping with regional patents and serving as a foundation for subsequent filings in the US, Europe, and Asia.
3. Can this patent be challenged or nullified?
Yes. Patents can be challenged through oppositions or invalidation proceedings, especially if prior art surfaces post-filing, or if the claims are deemed not to meet patentability requirements.
4. What strategies should licensees consider regarding KR20050090410?
They should evaluate the scope of claims for compatibility with their products, identify potential infringement risks, and consider licensing or designing around the patent to avoid litigation.
5. What are the implications for patent expiry on pharmaceutical exclusivity in Korea?
Upon expiry, the patent loses exclusivity, opening the market for generic competition. Therefore, patent management should include considering supplementary protections, such as data exclusivity or new method claims, especially in rapidly evolving therapeutic areas.
References
[1] Korean Intellectual Property Office (KIPO). Patent document KR20050090410.
[2] World Intellectual Property Organization (WIPO). Patent Landscape Reports.
[3] Kim, J., et al. (2020). “Pharmaceutical patent strategies in Korea,” Intellectual Property Journal.
[4] Korean Patent Act and Regulations.
[5] Market analysis reports on South Korean pharmaceutical patent filings.
